Abeona Therapeutics is Drug Discovery in United States that focus on Abeona Therapeutics Inc business. Founded in 1989. They cover business area such as Abeona Therapeutics Inc, gene therapy, plasma-base product, life-threaten rare genetic disease, its lead clinical program, an autologous, gene-correct cell therapy, recessive dystrophic epidermolysis bullosa, Sanfilippo syndrome type.
1989
( 35 years old in 2024 )
Abeona Therapeutics Inc
-
1330 Avenue of the Americas
33rd Floor
New York, NY 10019
United States
Private
Abeona Therapeutics Incgene therapyplasma-base productlife-threaten rare genetic diseaseits lead clinical programan autologous, gene-correct cell therapyrecessive dystrophic epidermolysis bullosaSanfilippo syndrome type
* We use standard office opening hours in near Abeona Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Abeona Therapeutics is Drug Discovery business from United States that founded in 1989 (35 years old in 2024), Abeona Therapeutics business is focusing on Abeona Therapeutics Inc.
Abeona Therapeutics headquarter office and corporate office address is located in 1330 Avenue of the Americas 33rd Floor New York, NY 10019 United States.
Abeona Therapeutics was founded in United States.
In 2024, Abeona Therapeutics is currently focus on Abeona Therapeutics Inc sector.
Above is snippet of Google Trends for "Abeona Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Abeona Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
